z-logo
Premium
New functional test for the TFPI α cofactor activity of Protein S working in synergy with FV ‐Short
Author(s) -
Dahlbäck Björn,
Guo Li Jun,
Zöller Bengt,
Tran Sinh
Publication year - 2019
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.14405
Subject(s) - protein s , tissue factor pathway inhibitor , cofactor , protein c , tissue factor , gene isoform , biochemistry , chemistry , microbiology and biotechnology , factor x , biology , thrombin , enzyme , platelet , coagulation , medicine , immunology , gene
Essentials Protein S and FV‐Short are synergistic cofactors to Tissue Factor Pathway Inhibitor α (TFPI α ). An assay for the TFPI α synergistic cofactor activity of protein S with FV‐Short was developed. The assay was specific for the synergistic TFPI α ‐cofactor activity of free protein S. Protein S deficient individuals with known mutations were correctly distinguished from controls.Summary Background Protein S is an anticoagulant cofactor to both activated protein C and tissue factor pathway inhibitor ( TFPI α ). The TFPI α ‐cofactor activity of protein S is stimulated by a short isoform of factor V ( FV ‐Short), the two proteins functioning in synergy. Objective Using the synergistic TFPI α ‐cofactor activity between protein S and FV ‐Short to develop a functional test for plasma protein S. Patients/Methods TFPI α ‐mediated inhibition of FX a in the presence of FV ‐Short, protein S and negatively charged phospholipid vesicles was monitored in time by synthetic substrate S2765. TFPI α , FX a and FV ‐Short were purified proteins, whereas diluted plasma from protein S deficient patients or controls were used as source for protein S. Results The assay was specific for free protein S demonstrating good correlation to free protein S plasma levels ( r  = 0.92) with a Y ‐axis intercept of −5%. Correlation to concentrations of total protein S (free and C4 BP β +‐bound) was lower ( r  = 0.88) and the Y ‐axis intercept was +46%, which is consistent with the specificity for free protein S. The test distinguished protein S‐deficient individuals from 6 families with known ProS1 mutations from family members having no mutation. Protein S levels of warfarin‐treated protein S deficient cases were lower than protein S in cases treated with warfarin for other causes. Conclusions We describe a new assay measuring the TFPI α ‐cofactor activity of plasma protein S. The test identifies type I/ III protein S deficiencies and will be a useful tool to detect type II protein S deficiency having defective TFPI α ‐cofactor activity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom